Tumagna, Pablita C.

HRN: 29-39-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2026
CEFTRIAXONE 1G (VIAL)
08/01/2026
08/08/2026
IV
2gm
OD
Fracture Close Complete Right Femur
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: